Compugen Ltd. Reports Q2 2024 Results
Ticker: CGEN · Form: 6-K · Filed: Aug 6, 2024 · CIK: 1119774
| Field | Detail |
|---|---|
| Company | Compugen Ltd (CGEN) |
| Form Type | 6-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, financial-results, foreign-issuer
TL;DR
Compugen dropped Q2 2024 earnings on Aug 6. Check the 6-K for details.
AI Summary
Compugen Ltd. reported its second quarter 2024 financial results on August 6, 2024. The filing, a Form 6-K, includes a press release detailing these results for the period ending June 30, 2024. Compugen is a foreign private issuer based in Israel.
Why It Matters
This filing provides investors with an update on Compugen's financial performance for the second quarter of 2024, offering insights into the company's operational and financial health.
Risk Assessment
Risk Level: low — This is a routine financial results filing (6-K) and does not contain new or unusual risk-related information.
Key Players & Entities
- Compugen Ltd. (company) — Registrant
- August 6, 2024 (date) — Date of press release
- June 30, 2024 (date) — End of reporting period
FAQ
What type of report is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
When did Compugen Ltd. file this report?
Compugen Ltd. filed this report on August 6, 2024.
What period do the reported results cover?
The reported results are for the second quarter of 2024, ending on June 30, 2024.
What is the primary document furnished with this 6-K?
The primary document furnished is a press release reporting the Company's 2024 second quarter results, filed as Exhibit 99.1.
Where is Compugen Ltd. based?
Compugen Ltd. is based in Holon, Israel.
Filing Stats: 490 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-08-06 07:00:42
Filing Documents
- zk2431742.htm (6-K) — 20KB
- exhibit_99-1.htm (EX-99.1) — 141KB
- exhibit_99-2.htm (EX-99.2) — 874KB
- exhibit_99-3.htm (EX-99.3) — 9KB
- image0.jpg (GRAPHIC) — 416KB
- 0001178913-24-002418.txt ( ) — 5344KB
- cgen-20240630.xsd (EX-101.SCH) — 41KB
- cgen-20240630_cal.xml (EX-101.CAL) — 37KB
- cgen-20240630_def.xml (EX-101.DEF) — 111KB
- cgen-20240630_lab.xml (EX-101.LAB) — 446KB
- cgen-20240630_pre.xml (EX-101.PRE) — 216KB
- zk2431742_htm.xml (XML) — 700KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. COMPUGEN LTD. Date: August 6, 2024 By: /s/ Eran Ben Dor Eran Ben Dor General Counsel